159 related articles for article (PubMed ID: 9324787)
21. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
Kakhnovskiĭ IM; Fomina IG; Ostroumov EL; Lepeshkov VM; Gaĭdamakina NE; Kaveshnikova OV; Markova ZS; Lugovaia EL
Ter Arkh; 1998; 70(8):29-33. PubMed ID: 9770740
[TBL] [Abstract][Full Text] [Related]
22. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
Azadpour M; Lamas GA
Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):891-902. PubMed ID: 15500434
[TBL] [Abstract][Full Text] [Related]
23. [Angiotensin-converting enzyme inhibitors and chronic ischemic heart disease--new indications?].
Haghfelt T; Haghfelt A
Ugeskr Laeger; 2004 Jan; 166(3):169-70. PubMed ID: 14870648
[No Abstract] [Full Text] [Related]
24. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Ferrari R; Ambrosio G; Chiariello M
Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
[No Abstract] [Full Text] [Related]
25. Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.
Kontopoulos AG; Athyros VG; Papageorgiou AA; Skeberis VM; Basayiannis EC; Boudoulas H
Coron Artery Dis; 1997; 8(8-9):517-24. PubMed ID: 9431480
[TBL] [Abstract][Full Text] [Related]
26. [The use of finoptin and alpha-tocopherol in patients with stable exertional stenocardia].
Levchenko VA; Serediuk NN; Gereliuk IP; Vakaliuk IP; Bondar' MM
Vrach Delo; 1990 Jan; (1):61-4. PubMed ID: 2330715
[TBL] [Abstract][Full Text] [Related]
27. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA
Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600
[TBL] [Abstract][Full Text] [Related]
28. [The use of trimetazidine in the combined therapy of postinfarct stenocardia].
Tereshchenko SN; Akimova OS; Tertychnaia GF
Ter Arkh; 1997; 69(1):68-9. PubMed ID: 9163058
[No Abstract] [Full Text] [Related]
29. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
[TBL] [Abstract][Full Text] [Related]
30. Medical therapy in patients undergoing percutaneous coronary intervention: results from the ROSETTA registry.
Eisenberg MJ; Okrainec K; Lefkovits J; Goudreau E; Deligonul U; Mak KH; Duerr R; Tsang J; Huynh T; Sedlis S; Brown DL; Brieger D; Pilote L;
Can J Cardiol; 2003 Aug; 19(9):1009-15. PubMed ID: 12915928
[TBL] [Abstract][Full Text] [Related]
31. Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
Sauer WH; Baer JT; Berlin JA; Kimmel SE
Am J Cardiol; 2004 Nov; 94(9):1171-3. PubMed ID: 15518614
[TBL] [Abstract][Full Text] [Related]
32. [Effect of various psychotropic drugs on the tolerance of patients with angina pectoris to dynamic and isometric exercise].
Volkov VS; Pozdniakov IuM; Trotsiuk VV; Vinogradov VF; Zin'kovskiĭ AK
Klin Med (Mosk); 1983 Mar; 61(3):23-8. PubMed ID: 6855152
[No Abstract] [Full Text] [Related]
33. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
Eliseev OM
Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
[No Abstract] [Full Text] [Related]
34. Loratidine improves ischemic parameters of exercise stress test in patients with acute myocardial infarction.
Erdogan O; Altun A; Gazi S; Ozbay G
Am Heart J; 2004 Dec; 148(6):e24. PubMed ID: 15632861
[TBL] [Abstract][Full Text] [Related]
35. [Pharmacodynamic comparison of propranolol and verapamil in exertion stenocardia].
Sumarokov AB; Romakov AIu; Sagirov AM; Iurkova VB; Mazur NA
Klin Med (Mosk); 1984 Mar; 62(3):42-6. PubMed ID: 6716929
[No Abstract] [Full Text] [Related]
36. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
[TBL] [Abstract][Full Text] [Related]
37. [The characteristics of postinfarct stenocardia and the recurrence of a myocardial infarct after thrombolytic therapy].
Chernetsov VA
Voen Med Zh; 1998 Sep; 319(9):59-63. PubMed ID: 9817019
[No Abstract] [Full Text] [Related]
38. [Stable angina pectoris can be treated successfully by drugs alone--pro].
Schneider CA; Erdmann E
Dtsch Med Wochenschr; 2007 Sep; 132(39):2024. PubMed ID: 17882742
[No Abstract] [Full Text] [Related]
39. [Angiotensin-converting enzyme inhibitors in angina pectoris].
Bussmann WD; Goerke S; Schneider W; Kaltenbach M
Dtsch Med Wochenschr; 1988 Apr; 113(14):548-50. PubMed ID: 3356181
[TBL] [Abstract][Full Text] [Related]
40. Impact of an initial strategy of medical therapy without percutaneous coronary intervention in high-risk patients from the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation (COURAGE) trial.
Maron DJ; Spertus JA; Mancini GB; Hartigan PM; Sedlis SP; Bates ER; Kostuk WJ; Dada M; Berman DS; Shaw LJ; Chaitman BR; Teo KK; O'Rourke RA; Weintraub WS; Boden WE;
Am J Cardiol; 2009 Oct; 104(8):1055-62. PubMed ID: 19801024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
